Polaryx Therapeutics, Inc. (PLYX)
Form 4 sales, Form 144 notices and lockup dates Pharmaceutical Preparations, in Pharma.
- Latest sale
- None
- No Form 4 sale on record
- Form 4 sales
- 0
- On record
- Form 144 notices
- 0
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
No Form 4 sale on record.
Timeline
No filings yet.
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| May 27, 2026 | May 28, 2026 | PLYX | Mstone Partners Healthcare Ltd | Director, 10% owner | Bought | 88,453 | $4.07 | $360k | 24.2M | SEC |
| Feb 18, 2026 | Feb 20, 2026 | PLYX | Landis G. Michael | Chief Financial Officer | Bought | 2,867 | $2.79 | $8k | 228,225 | SEC |